BioNexus Gene Lab
BGLC
BGLC
5 hedge funds and large institutions have $171K invested in BioNexus Gene Lab in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$50K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$43.5K |
| 3 |
HF
HRT Financial
New York
|
+$38K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$20K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.9K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $50K | +$50K | +5,969 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $43.5K | +$43.5K | +5,175 | New |
|
|
HF
3
HRT Financial
New York
| $38K | +$38K | +4,547 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $20K | +$20K | +2,299 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $19.9K | +$19.9K | +2,368 | New |
|